Start an analysis for THRM
Gentherm Inc
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $550m | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Remaining authorization | $550mEST | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Program expiry | 30-Jun-27 | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| Not found in filings | $400m | $400mEST | 27-Jul-29 | In July 2026, the Board terminated the 2024 Stock Repurchase Program and authorized a new stock repurchase program (the “2026 Stock Repurchase Program”), pursuant to which the Company is authorized to repurchase up to $400.0 million of its issued and outstanding Common Stock over a three-year period, expiring July 27, 2029.10-Q filed 22-Oct-26 |
| Not found in filings | $150m | $150mEST | 30-Jun-27 | Under the 2024 Stock Repurchase Program, the Company was authorized to repurchase up to $150.0 million of its issued and outstanding Common Stock over a three-year period, expiring June 30, 2027.10-Q filed 22-Oct-26 |
Open-market repurchases
None reported in the filings we hold.